IRIS
ATZENI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.267
EU - Europa 2.309
AS - Asia 1.422
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
OC - Oceania 2
Totale 8.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.257
IE - Irlanda 1.242
CN - Cina 757
SE - Svezia 632
SG - Singapore 545
IT - Italia 243
IN - India 71
PL - Polonia 70
BE - Belgio 19
FI - Finlandia 19
DE - Germania 18
GB - Regno Unito 15
VN - Vietnam 15
BR - Brasile 11
NL - Olanda 11
CA - Canada 10
FR - Francia 9
IR - Iran 7
EU - Europa 6
IQ - Iraq 6
UA - Ucraina 6
AR - Argentina 5
CH - Svizzera 5
ES - Italia 5
ID - Indonesia 5
TR - Turchia 5
DK - Danimarca 4
EG - Egitto 4
RU - Federazione Russa 4
PT - Portogallo 3
AU - Australia 2
CO - Colombia 2
KZ - Kazakistan 2
QA - Qatar 2
SA - Arabia Saudita 2
AT - Austria 1
BD - Bangladesh 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
JO - Giordania 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
Totale 8.028
Salva come PNG Salva come JPEG
Città #
Dublin 1.240
Chandler 1.010
Nyköping 462
Singapore 429
Beijing 417
New York 291
Princeton 271
Jacksonville 248
Dearborn 245
Medford 228
Des Moines 199
Cambridge 167
Ashburn 111
Ann Arbor 74
Warsaw 69
Wilmington 59
Pune 58
Messina 57
Nanjing 42
Shenyang 40
Jinan 33
Los Angeles 28
Boardman 22
Falls Church 21
Brussels 19
San Mateo 19
Haikou 18
Hebei 18
Ningbo 18
Catania 17
Guangzhou 17
Zhengzhou 16
Norwalk 15
Dong Ket 14
Hangzhou 14
Nanchang 14
Rome 14
Seattle 14
Tianjin 14
Changsha 10
Fuzhou 10
Leawood 10
Jiaxing 9
Lappeenranta 8
Milan 8
Taizhou 8
Caltagirone 7
Florence 7
Piazza Armerina 7
Redwood City 7
Washington 7
Hefei 6
London 6
Padova 6
Amsterdam 5
Ardabil 5
Buenos Aires 5
Cagliari 5
Jakarta 5
Lanzhou 5
Monmouth Junction 5
Paris 5
San Lorenzo del Vallo 5
Taiyuan 5
Bremen 4
Helsinki 4
Houston 4
Prineville 4
Turin 4
Augusta 3
Chengdu 3
Erbil 3
Gioiosa Marea 3
Hyderabad 3
Iowa City 3
Istanbul 3
Itu 3
Milwaukee 3
Mountain View 3
Porto 3
Shanghai 3
São Paulo 3
Woodbridge 3
Almaty 2
Atlanta 2
Bello 2
Buffalo 2
Cairo 2
Cangzhou 2
Changle 2
Clifton 2
Concord 2
Davis 2
Fairfield 2
Forest City 2
Frankfurt am Main 2
Genoa 2
Giza 2
Lyon 2
Modena 2
Totale 6.324
Salva come PNG Salva come JPEG
Nome #
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 75
Algo-dysfunctional syndromes: a critical digest of the recent literature 69
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 68
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 66
Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria? 61
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 59
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 58
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 57
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 56
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 55
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 55
Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National Register 54
Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound 54
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis 53
TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same? 52
B Lymphocyte intestinal homing in inflammatory bowel disease 51
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 51
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 51
Biomarkers in Rheumatoid Arthritis 50
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 50
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry 50
Immunogenicity and autoimmunity during anti-TNF therapy 49
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 47
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 47
Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: An assessment of combined tests 47
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 46
Web/Internet-based telemonitoring of a randomized controlled trial evaluating the time-integrated effects of a 24-week multicomponent intervention on key health outcomes in patients with fibromyalgia 46
From autoinflammation to autoimmunity: old and recent findings 46
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 46
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 46
EULAR recommendations for management of fibromyalgia 46
Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases 45
Chronic widespread pain in the spectrum of rheumatological diseases 45
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 45
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 45
Rationale underlying the measurement of fractional exhaled nitric oxide in systemic sclerosis patients 44
Autoantibody profile during short-term infliximab treatment for Crohn's disease: A prospective cohort study 44
EULAR revised recommendations for the management of fibromyalgia 44
Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies? 44
Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis 44
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 44
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update 43
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis 43
Measurement of Serum Klotho in Systemic Sclerosis 43
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: Results of an italian multicentre study 43
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 43
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 43
AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS) 43
Systemic rheumatic diseases: from biological agents to small molecules 43
Predicting response to anti-TNF treatment in rheumatoid arthritis patients 43
Cardiovascular involvement in systemic autoimmune diseases 42
Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjögren's syndrome? 42
Autoimmune hepatitis and allergic reactions during anti-TNFα treatment 42
One year in review 2019: fibromyalgia 42
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 42
Impaired lung transfer factor in fibromyalgia syndrome 42
Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease 41
A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data 41
null 41
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 41
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 40
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3 40
Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value 40
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 40
Psoriatic arthritis registries 40
Safety of Abatacept in Rheumatoid Arthritis with Serologic Evidence of Past or Present Hepatitis B Virus Infection 39
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: A one-year prospective study 39
CC chemokine receptor 5 polymorphism in Italian patients with Beḩet's disease 39
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 39
Rheumatic diseases and autoimmune vascular dementia 39
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 39
Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents 39
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients 39
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 39
Clinical comparison of QUANTA flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies 38
Pain in systemic connective tissue diseases 38
PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease 38
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 38
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome 38
Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography 38
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: A cross-sectional study from the Big Data Sjögren’s Project Consortium 38
Low risk of hepatitis B virus reactivation in HBsAg-negative/anti-HBc-positive carriers receiving rituximab for rheumatoid arthritis: A retrospective multicenter Italian study 37
Features of mood associated with high body weight in females with fibromyalgia 37
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 37
A possible link between ankylosing spondylitis and periodontitis: A systematic review and meta-analysis 37
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 37
Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort 37
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 37
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 37
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry 36
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: Real-life data from the LORHEN registry 36
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 36
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 36
Pain in systemic sclerosis 36
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project) 36
Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? 36
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 36
Measuring psoriatic disease in clinical practice. An expert opinion position paper 35
Cardiovascular and autoimmune diseases in females: The role of microvasculature and dysfunctional endothelium 35
Costs associated with rheumatoid arthritis in Italy: past, present, and future 35
Totale 4.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020982 0 0 0 0 13 190 188 63 91 188 214 35
2020/2021836 10 16 183 23 272 13 51 97 59 47 48 17
2021/20221.185 9 60 4 30 97 21 28 51 36 55 170 624
2022/20233.463 313 223 155 315 169 350 21 199 1.567 14 110 27
2023/20241.125 94 134 193 83 69 388 7 33 4 32 7 81
2024/2025644 74 44 94 297 135 0 0 0 0 0 0 0
Totale 8.627